Finding:

1. close

   Bavituximab

   Bavituximab is a chimeric Anti-PS monoclonal antibody analog which is used to potentially treat cancers and viral infections. ... Bavituximab-treated survivors were immune to reinfection.
2. close

   Infliximab

   At 2 months, the response was 61-69% for patients treated with infliximab, and 31% for those who were treated with placebo. ... Bavituximab, Cetuximab, Rituximab
3. close

   Monoclonal antibodies

   | trastuzumab | anti-cancer therapy for a specific kind of breast cancer | targets the HER2/neu (erbB2) receptor | humanized | ... Bavituximab, Cetuximab, Rituximab
4. close

   Cetuximab

   Cetuximab (IMC-C225 -- marketed under the name Erbitux) is a chimeric monoclonal antibody, an epidermal growth factor receptor (EGFR) inhibitor, given by intravenous injection for treatment of metastatic colorectal cancer and head and neck cancer. ... Bavituximab, Cetuximab, Rituximab
5. close

   Rituximab

   Several patients with systemic lupus erythematosus have died after being treated with rituximab. ... Bavituximab, Cetuximab, Rituximab
6. close

   Abciximab

   Abciximab-induced thrombocytopenia can typically be treated with transfusion of platelets. ... Bavituximab, Cetuximab, Rituximab
7. close

   Pagibaximab

   Chimeric monoclonal antibodies ("-xi-") "-tuxi-" (tumor/cancer immunotherapy) Bavituximab, Cetuximab, Rituximab
8. close

   Volociximab

   Chimeric monoclonal antibodies ("-xi-") "-tuxi-" (tumor/cancer immunotherapy) Bavituximab, Cetuximab, Rituximab
9. close

   Ecromeximab

   Ecromeximab is a chimeric monoclonal antibody is used in the treatment of malignant melanoma. ... Bavituximab, Cetuximab, Rituximab
10. close

    Basiliximab

    Chimeric monoclonal antibodies ("-xi-") "-tuxi-" (tumor/cancer immunotherapy) Bavituximab, Cetuximab, Rituximab

Explore the following pages on Powerset:

• Bavituximab,
• Infliximab,
• Monoclonal antibodies,
• Cetuximab,
• Rituximab,
• Abciximab,
• Pagibaximab,
• Volociximab,
• Ecromeximab,
• Basiliximab